BREAKING: Study Identifies Over 300 Peer-Reviewed COVID-19 “Vaccine” Cancer Cases Across 27 Countries — Journal Hit With Cyberattacks

For several years now, clinicians, pathologists, and independent researchers have been documenting turbo cancers following COVID-19 vaccination: sudden relapses, explosive disease acceleration, rare malignancies appearing out of nowhere, and tumors localizing to injection sites or draining lymph nodes. These signals have been visible for some time — but deliberately fragmented, dismissed as coincidence, or buried under claims that “case reports don’t count.”

That excuse has now completely collapsed.

A newly published peer-reviewed systematic review in Oncotarget — authored by Charlotte Kuperwasser, PhD, and Wafik S. El-Deiry, MD, PhD — is the first to formally assemble and analyze the entire published literature on cancer temporally associated with COVID-19 vaccination and SARS-CoV-2 infection.

Importantly, while this article has been accepted, published, and assigned a publication date, the journal has disclosed that it is currently unable to add the paper to its live journal index due to an ongoing malicious cyberattack on its servers. According to a statement now posted on Oncotarget’s website — and relayed directly to us by Dr. El-Deiry — the journal experienced sustained cyber intrusions in December 2025 and January 2026, which were reported to the FBI, with attacks continuing into the present. In the meantime, Dr. El-Deiry has provided a link to access this important paper. You can read it here.